跳至主要内容
临床试验/NCT05092139
NCT05092139已完成不适用

enDovascular trEatmenT for acutE isChemic sTroke in China (DETECT2-China): a Prospective, National, Multi-center, Registry Study

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年1月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,000
试验地点
1
主要终点
Proportion of patients with modified Rankin Score 0 to 2

研究概览

简要总结

This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: ≥ 18;
  • Ischemic stroke confirmed by head CT or MRI;
  • Patients receiving endovascular treatment;
  • First ever stroke or pre-stroke mRS≤2;
  • signed informed consent.

排除标准

  • Prestroke mRS≥3;
  • Other serious illness that would confound the clinical outcome at 90 days;
  • Unavailable neuroimaging data;
  • Other unsuitable conditions judged by the investigator

结局指标

主要结局

Proportion of patients with modified Rankin Score 0 to 2

时间窗: Day 90

the minimum and maximum values of modified Rankin Score are 0 and 6, respectively; higher score mean a worse outcome

次要结局

  • Proportion of death(7 days)
  • Proportion of patients with modified Rankin Score 0 to 1(Day 90)
  • Distribution of modified Rankin Score(Day 90)
  • Proportion of symptomatic intracranial hemorrhage (sICH)(48 hours)
  • Changes in National Institute of Health stroke scale (NIHSS)(24 hours, 48 hours, and 2 weeks)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Sheng Chen

Head of Neurology

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验